Novo Nordisk Data Breach Hits Clinical Trials
The Novo Nordisk data breach has pushed one of the world’s most watched pharmaceutical companies into a difficult spotlight, not because of a new drug launch or a market-moving trial update, but because sensitive clinical trial information was copied without authorization. In an industry built on trust, science, and carefully guarded patient records, that kind […]